Despite the worse outcomes in the German group, comparison of recovery rates from optic neuritis and/or transverse myelitis attacks to previously published rates for AQP4-NMOSD showed an improved recovery rate (more complete and less partial/no recovery) [22], but less than observed with MS [109,185]. This evidence concerns the gene AQP4 and optic neuritis.